Panel Lays Out Guidelines for CRISPR-Edited Human Embryos

The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: Science